FXR inhibitor, Z-GS, showed a favorable therapeutic effect in decreasing FXR/IL-6/IL-6ST/p-STAT3 axis and treating FXRhigh NSCLC metastasis in mouse models in vivo. The gene discussed is IL6ST; the disease is non-small cell lung carcinoma.